Inhibikase Therapeutics Stock Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 12.02%

The Inhibikase Therapeutics, Inc. stock price gained 3.54% on the last trading day (Tuesday, 7th Jul 2026), rising from $1.98 to $2.05. During the last trading day the stock fluctuated 7.61% from a day low at $1.97 to a day high of $2.12. The price has risen in 6 of the last 10 days and is up by 11.41% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 852 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $2.59 million.

The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $2.08 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect Inhibikase Therapeutics, Inc. stock with a 90% probability to be traded between $1.62 and $2.12 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

IKT Signals & Forecast

Mostly positive signals in the chart today. The Inhibikase Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.98 and $1.76. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 30.57%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Inhibikase Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.91 and $1.70. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Inhibikase Therapeutics, Inc. finds support just below today's level at $1.91. If this is broken, then the next support from accumulated volume will be at $1.70 and $1.67.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.150 between high and low, or 7.61%. For the last week, the stock has had daily average volatility of 6.83%.

The Inhibikase Therapeutics, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $1.98 (-3.34%) (This stock has high daily movements and this gives high risk. The RSI14 is 83 and this increases the risk substantially. There is a buy signal from a pivot bottom found 32 days ago.)

Trading Expectations (IKT) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Inhibikase Therapeutics, Inc. to open at $2.05, and during the day (based on 14 day Average True Range), to move between $2.00 and $2.10, which gives a possible trading interval of +/-$0.0975 (+/-4.87%) up or down from last closing price. If Inhibikase Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.06 (0.49%) than the support at $1.91 (6.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Inhibikase Therapeutics, Inc. stock A Buy?

Inhibikase Therapeutics, Inc. holds several positive signals and is considered to be a good choice at current levels. We expect the Inhibikase Therapeutics, Inc. stock to perform great in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.862 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $2.05 ( 0.163%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk